{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:41:35Z","timestamp":1793392895808,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Asia"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jacasi.2025.07.015","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T15:54:20Z","timestamp":1757087660000},"page":"1487-1501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association and Prognostic Implications of \u201cNo-Reflow Phenomenon\u201d and Hypercoagulability in Patients With ST-Segment Elevation Myocardial Infarction"],"prefix":"10.1016","volume":"5","author":[{"given":"Mohamed","family":"Omar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Gyu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Ki","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Hwa","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2920-7411","authenticated-orcid":false,"given":"Jin-Sin","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil Iver","family":"Guevarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7208-8596","authenticated-orcid":false,"given":"Sang-Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udaya S.","family":"Tantry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Gurbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Yong","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0403-3726","authenticated-orcid":false,"given":"Young-Hoon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jacasi.2025.07.015_bib1","first-page":"563","article-title":"State of the art: no-reflow phenomenon","volume":"38","author":"Caiazzo","year":"2020","journal-title":"Cardiol Clin"},{"issue":"38","key":"10.1016\/j.jacasi.2025.07.015_bib2","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.jacasi.2025.07.015_bib3","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1172\/JCI107898","article-title":"The \"no-reflow\" phenomenon after temporary coronary occlusion in the dog","volume":"54","author":"Kloner","year":"1974","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.jacasi.2025.07.015_bib4","first-page":"950","article-title":"Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory","volume":"72","author":"Rezkalla","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.jacasi.2025.07.015_bib5","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjcard.2006.08.054","article-title":"Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality","volume":"99","author":"Brosh","year":"2007","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.jacasi.2025.07.015_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCINTERVENTIONS.109.896225","article-title":"Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction","volume":"3","author":"Ndrepepa","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"issue":"19","key":"10.1016\/j.jacasi.2025.07.015_bib7","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/eurheartj\/ehad088","article-title":"Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction","volume":"44","author":"Lee","year":"2023","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.jacasi.2025.07.015_bib8","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jacasi.2025.07.015_bib9","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Writing Committee Members","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.jacasi.2025.07.015_bib10","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM198504043121437","article-title":"The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings","volume":"312","year":"1985","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jacasi.2025.07.015_bib11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3390\/biomedicines12040802","article-title":"Myocardial ischemia-reperfusion injury: unraveling pathophysiology, clinical manifestations, and emerging prevention strategies","volume":"12","author":"Sagris","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.jacasi.2025.07.015_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ahj.2012.03.022","article-title":"Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies","volume":"164","author":"Jeong","year":"2012","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.jacasi.2025.07.015_bib13","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1160\/TH13-08-0643","article-title":"Thrombin-induced platelet-fibrin clot strength: relation to high on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes","volume":"111","author":"Jeong","year":"2014","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.jacasi.2025.07.015_bib14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s11239-020-02103-w","article-title":"The impact of platelet-fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease","volume":"50","author":"Bae","year":"2020","journal-title":"J Thromb Thrombolysis"},{"issue":"9","key":"10.1016\/j.jacasi.2025.07.015_bib15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacc.2023.04.003","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"82","author":"Writing Committee Members","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jacasi.2025.07.015_bib16","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.4244\/EIJ-D-23-00112","article-title":"No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL Trial","volume":"19","author":"d'Entremont","year":"2023","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.jacasi.2025.07.015_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2217\/bmm.10.55","article-title":"Predicting the no-reflow phenomenon following successful percutaneous coronary intervention","volume":"4","author":"Galiuto","year":"2010","journal-title":"Biomark Med"},{"issue":"2","key":"10.1016\/j.jacasi.2025.07.015_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijcard.2008.11.189","article-title":"Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction","volume":"141","author":"Jeong","year":"2010","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.jacasi.2025.07.015_bib19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1055\/s-0030-1265286","article-title":"Clinical utility of thromboelastography: one size does not fit all","volume":"36","author":"Wegner","year":"2010","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"10.1016\/j.jacasi.2025.07.015_bib20","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s11239-020-02240-2","article-title":"Viscoelastic properties of clot formation and their clinical impact in East Asian versus Caucasian patients with stable coronary artery disease: a COMPARE-RACE analysis","volume":"51","author":"Jeong","year":"2021","journal-title":"J Thromb Thrombolysis"},{"issue":"8","key":"10.1016\/j.jacasi.2025.07.015_bib21","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jacc.2008.10.045","volume":"53","author":"Gurbel","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacasi.2025.07.015_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11239-016-1399-3","article-title":"Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation","volume":"42","author":"Lau","year":"2016","journal-title":"J Thromb Thrombolysis"},{"issue":"11","key":"10.1016\/j.jacasi.2025.07.015_bib23","first-page":"1615","article-title":"Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate","volume":"52","author":"Dinkelaar","year":"2014","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"10.1016\/j.jacasi.2025.07.015_bib24","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.amjcard.2019.01.031","article-title":"Effects of cangrelor as adjunct therapy to percutaneous coronary intervention","volume":"123","author":"Hideo-Kajita","year":"2019","journal-title":"Am J Cardiol"},{"issue":"9-10","key":"10.1016\/j.jacasi.2025.07.015_bib25","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jacbts.2021.08.007","article-title":"Association between thrombogenicity indices and coronary microvascular dysfunction in patients with acute myocardial infarction","volume":"6","author":"Kang","year":"2021","journal-title":"JACC Basic Transl Sci"},{"issue":"13","key":"10.1016\/j.jacasi.2025.07.015_bib26","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/eurheartj\/ehy013","article-title":"Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy","volume":"39","author":"Sumaya","year":"2018","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.jacasi.2025.07.015_bib27","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MBC.0b013e32835e4219","article-title":"Differential profiles of thrombin inhibitors (heparin, hirudin, bivalirudin, and dabigatran) in the thrombin generation assay and thromboelastography in vitro","volume":"24","author":"Xu","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"12","key":"10.1016\/j.jacasi.2025.07.015_bib28","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.3390\/jcm10122720","article-title":"Effects of monotherapy with clopidogrel vs. aspirin on vascular function and hemostatic measurements in patients with coronary artery disease: the prospective, crossover I-LOVE-MONO Trial","volume":"10","author":"Park","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.jacasi.2025.07.015_bib29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s11239-016-1399-3","article-title":"Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation","volume":"42","author":"Lau","year":"2016","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"10.1016\/j.jacasi.2025.07.015_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0039-1695772","article-title":"Effects of edoxaban on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel: results of the EDOX-APT study","volume":"120","author":"Franchi","year":"2020","journal-title":"Thromb Haemost"},{"issue":"23","key":"10.1016\/j.jacasi.2025.07.015_bib31","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1161\/CIRCULATIONAHA.119.041766","article-title":"Clinically significant bleeding with ticagrelor versus clopidogrel in Korean patients with acute coronary syndromes intended for invasive management: a randomized clinical trial","volume":"140","author":"Park","year":"2019","journal-title":"Circulation"}],"container-title":["JACC: Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374725003904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374725003904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T04:00:40Z","timestamp":1763784040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772374725003904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2772374725003904"],"URL":"https:\/\/doi.org\/10.1016\/j.jacasi.2025.07.015","relation":{},"ISSN":["2772-3747"],"issn-type":[{"value":"2772-3747","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association and Prognostic Implications of \u201cNo-Reflow Phenomenon\u201d and Hypercoagulability in Patients With ST-Segment Elevation Myocardial Infarction","name":"articletitle","label":"Article Title"},{"value":"JACC: Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacasi.2025.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}